News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,553 Results
Type
Article (4358)
Company Profile (95)
Press Release (132095)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (42082)
Career Advice (209)
Deals (6162)
Drug Delivery (15)
Drug Development (17424)
Employer Resources (18)
FDA (1494)
Job Trends (2789)
News (66223)
Policy (3658)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (294)
Accelerated approval (8)
Adcomms (1)
Allergies (34)
Alliances (11493)
ALS (54)
Alzheimer's disease (435)
Antibody-drug conjugate (ADC) (102)
Approvals (1579)
Artificial intelligence (105)
Autoimmune disease (66)
Automation (13)
Bankruptcy (38)
Best Places to Work (2248)
BIOSECURE Act (14)
Biosimilars (25)
Biotechnology (86)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (189)
Cancer (1359)
Cardiovascular disease (50)
Career advice (201)
Career pathing (5)
CAR-T (127)
Cell therapy (324)
Cervical cancer (9)
Clinical research (15442)
Collaboration (569)
Compensation (282)
Complete response letters (5)
COVID-19 (442)
CRISPR (25)
C-suite (375)
Cystic fibrosis (45)
Data (1967)
Depression (21)
Diabetes (105)
Diagnostics (752)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (95)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (51)
Earnings (13378)
Editorial (5)
Employer resources (18)
Events (26365)
Executive appointments (388)
FDA (2191)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (481)
Gene editing (54)
Generative AI (12)
Gene therapy (170)
GLP-1 (165)
Government (363)
Guidances (71)
Healthcare (1534)
HIV (9)
Huntington's disease (13)
IgA nephropathy (40)
Immunology and inflammation (70)
Immuno-oncology (14)
Indications (27)
Infectious disease (501)
Inflammatory bowel disease (76)
Inflation Reduction Act (1)
Influenza (37)
Intellectual property (79)
Interviews (18)
IPO (2967)
IRA (4)
Job creations (668)
Job search strategy (184)
JPM (3)
Kidney cancer (3)
Labor market (16)
Layoffs (42)
Leadership (2)
Legal (641)
Liver cancer (16)
Longevity (2)
Lung cancer (128)
Lymphoma (145)
Machine learning (15)
Management (4)
Manufacturing (248)
MASH (19)
Medical device (407)
Medtech (409)
Mergers & acquisitions (3536)
Metabolic disorders (228)
Multiple sclerosis (54)
NASH (1)
Neurodegenerative disease (83)
Neuropsychiatric disorders (15)
Neuroscience (769)
Neurotech (1)
NextGen: Class of 2026 (859)
Non-profit (277)
Now hiring (7)
Obesity (97)
Opinion (41)
Ovarian cancer (69)
Pain (44)
Pancreatic cancer (74)
Parkinson's disease (105)
Partnered (6)
Patents (134)
Patient recruitment (161)
Peanut (17)
People (17156)
Pharmaceutical (8)
Phase 1 (6096)
Phase 2 (7391)
Phase 3 (3796)
Pipeline (1502)
Policy (33)
Postmarket research (209)
Preclinical (2634)
Press Release (51)
Prostate cancer (49)
Psychedelics (5)
Radiopharmaceuticals (51)
Rare diseases (169)
Real estate (1461)
Recruiting (10)
Regulatory (3447)
Reports (15)
Research institute (311)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (13)
Schizophrenia (17)
Series A (92)
Series B (75)
Service/supplier (2)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (40)
Sponsored (5)
Startups (991)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (9)
The Weekly (4)
Vaccines (127)
Venture capital (19)
Weight loss (41)
Women's health (9)
Worklife (2)
Date
Today (13)
Last 7 days (139)
Last 30 days (531)
Last 365 days (8470)
2026 (950)
2025 (8540)
2024 (9140)
2023 (9883)
2022 (11995)
2021 (12643)
2020 (9849)
2019 (6672)
2018 (5275)
2017 (6073)
2016 (5592)
2015 (6439)
2014 (4922)
2013 (4060)
2012 (4397)
2011 (4870)
2010 (4514)
Location
Africa (144)
Alabama (52)
Alaska (1)
Arizona (36)
Arkansas (2)
Asia (8948)
Australia (2080)
California (3662)
Canada (913)
China (280)
Colorado (73)
Connecticut (128)
Delaware (56)
Europe (19512)
Florida (384)
Georgia (54)
Hawaii (2)
Idaho (11)
Illinois (180)
India (18)
Indiana (198)
Iowa (3)
Japan (106)
Kansas (15)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (377)
Massachusetts (2760)
Michigan (97)
Minnesota (158)
Mississippi (1)
Missouri (11)
Montana (11)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (683)
New Mexico (6)
New York (808)
North Carolina (446)
North Dakota (5)
Northern California (1805)
Ohio (68)
Oklahoma (7)
Oregon (7)
Pennsylvania (634)
Puerto Rico (9)
Rhode Island (6)
South America (202)
South Carolina (4)
Southern California (1443)
Tennessee (23)
Texas (479)
United States (11525)
Utah (35)
Virginia (27)
Washington D.C. (9)
Washington State (507)
West Virginia (1)
Wisconsin (21)
136,553 Results for "trilink biotechnologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 3, 2025
·
3 min read
Press Releases
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
May 14, 2025
·
4 min read
Press Releases
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery.
May 13, 2024
·
3 min read
Press Releases
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
February 4, 2025
·
4 min read
Press Releases
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
·
4 min read
Press Releases
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility.
April 18, 2024
·
5 min read
Press Releases
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.
April 30, 2024
·
2 min read
Press Releases
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
February 5, 2025
·
3 min read
Press Releases
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has been granted patents by the China National Intellectual Property Administration and the Canadian Intellectual Property Office.
February 21, 2024
·
4 min read
Press Releases
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
TriLink BioTechnologies®, a Maravai LifeSciences company and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence hub.
November 2, 2023
·
6 min read
1 of 13,656
Next
